Ubs Group Ag Edgewise Therapeutics, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 92,066 shares of EWTX stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,066
Previous 75,305
22.26%
Holding current value
$2.26 Million
Previous $2.01 Million
22.35%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$369 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$219 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$151 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$148 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$123 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.55B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...